Research Paper Volume 15, Issue 9 pp 3572—3585
Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients
Figure 2. Box plot evaluating SEMA6B mRNA expression differences among THCA patients with different clinical characteristics including disease stages (TNM staging system) (A–C), tumor pathologic stages (D), primary neoplasm focus type (E) and state of extrathyroidal extension (F).